Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 178,196 shares at $12.15 ($2.2M) on 2018-02-01, disclosed to the SEC on 2018-02-05.
Open-market sale of $2.2M CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.15 | 88,098 | $1.1M | 49.4% |
| 2 | $12.15 | 88,098 | $1.1M | 49.4% |
| 3 | $12.11 | 2,000 | $24K | 1.1% |
| Total | $12.15 avg | 178,196 | $2.2M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |